Company Growth (employees)
Bristol-Myers Squibb was founded in 1887 and is headquartered in New York, US
Key People at Bristol-Myers Squibb
Giovanni Caforio
Chief Executive Officer
Charles Bancroft
Executive Vice President, CFO
Francis Cuss
Executive Vice President and Chief Scientific Officer
Lamberto Andreotti
Chairman, Board of Directors
Bristol-Myers Squibb Office Locations
Bristol-Myers Squibb has offices in New York, Jacksonville, Atlanta, Birmingham and in 164 other locations
New York, US (HQ)
345 Park Avenue
Bristol-Myers Squibb Data and Metrics
Bristol-Myers Squibb Financial Metrics
Bristol-Myers Squibb's revenue was reported to be $19.4 b in FY, 2016 which is a 17% increase from the previous period.
USD
Revenue (FY, 2016) | 19.4 b |
Revenue growth (FY, 2015 - FY, 2016), % | 17% |
Gross profit (FY, 2016) | 14.5 b |
Gross profit margin (FY, 2016), % | 75% |
Net income (FY, 2016) | 4.5 b |
Market capitalization (17-Aug-2017) | 93.3 b |
Cash (31-Dec-2016) | 4.2 b |
EV | 95.8 b |
Bristol-Myers Squibb's current market capitalization is $93.3 b.
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Revenue | 16.4 b | 15.9 b | 16.6 b | 19.4 b |
Revenue growth, % | (3%) | 4% | 17% | |
Cost of goods sold | 4.6 b | 3.9 b | 3.9 b | 4.9 b |
Gross profit | 11.8 b | 11.9 b | 12.7 b | 14.5 b |
Gross profit Margin, % | 72% | 75% | 76% | 75% |
Operating expense total | 13.5 b | 13.5 b | 14.5 b | 13.5 b |
Pre tax profit | 2.9 b | 2.4 b | 2.1 b | 5.9 b |
Income tax expense | 311 m | 352 m | 446 m | 1.4 b |
Net Income | 2.6 b | 2 b | 1.6 b | 4.5 b |
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 3.6 b | 5.6 b | 2.4 b | 4.2 b |
Inventories | 1.5 b | 1.6 b | 1.2 b | 1.2 b |
Current Assets | 18.9 b | 14.6 b | 10.4 b | 13.7 b |
Goodwill | 7.1 b | 7 b | 6.9 b | 6.9 b |
Total Assets | 38.6 b | 33.7 b | 31.7 b | 33.7 b |
Accounts Payable | 2.6 b | 2.5 b | 1.6 b | 1.7 b |
Dividends Payable | 634 m | 645 m | 655 m | |
Total Debt | 8.3 b | 7.8 b | 6.7 b | 6.7 b |
Current Liabilities | 12.4 b | 8.5 b | 8 b | 8.8 b |
Retained Earnings | 33 b | 32.5 b | 31.6 b | 33.5 b |
Total Equity | 15.2 b | 15 b | 14.4 b | 16.3 b |
Debt to Equity Ratio | 0.5 x | 0.5 x | 0.5 x | 0.4 x |
Debt to Assets Ratio | 0.2 x | 0.2 x | 0.2 x | 0.2 x |
Financial Leverage | 2.5 x | 2.3 x | 2.2 x | 2.1 x |
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | 2.6 b | 2 b | 1.6 b | 4.5 b |
Inventories | (45 m) | (254 m) | 97 m | (152 m) |
Accounts Payable | 412 m | (44 m) | (919 m) | 104 m |
Cash From Operating Activities | 3.5 b | 3.1 b | 1.8 b | 2.9 b |
Capital Expenditures | (820 m) | (1.2 b) | ||
Cash From Investing Activities | (572 m) | 1.2 b | (1.6 b) | 1.5 b |
Long-term Borrowings | (597 m) | (676 m) | (2 b) | (15 m) |
Cash From Financing Activities | (1.1 b) | (2.4 b) | (3.4 b) | (2.4 b) |
Free Cash Flow | 2.7 b | 4.1 b |
| USD | Y, 2016 |
|---|---|
EV/CFO | 33.6 x |
EV/FCF | 23.6 x |
Revenue/Employee | 777.1 k |
Debt/Equity | 0.4 x |
Debt/Assets | 0.2 x |
Financial Leverage | 2.1 x |
Bristol-Myers Squibb Market Value History
Bristol-Myers Squibb Median Salaries
Source: 359 public H-1B filings from Bristol-Myers Squibb
